• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREP2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREP2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 05168589190
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/18/2023
Event Type  malfunction  
Manufacturer Narrative
The serial number of the cobas 8000 c702 module is (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with crep2 (creatinine) on a cobas 8000 c702 module.The sample initially resulted in a creatinine value of 72 umol/l.The sample was then repeated using the creatinine jaffe method and the creatinine value was 169 umol/l.The sample was then diluted 1:3 and repeated using the original crep2 method and the creatinine value was 105 umol/l accompanied by a data flag.The 169 umol/l value was reported to the patient because it agreed with the patient's clinical picture.
 
Manufacturer Narrative
A sample from the patient was provided for investigation.Initial investigations of the patient sample were able to duplicate the results obtained by the customer.The patient was diagnosed with hydrocephalus, sepsis, insulin-dependent diabetes mellitus, and pneumonia.The complained patient sample had a high glucose concentration of 34.07 mmol/l.The patient's total protein level was not elevated.Medwatch field d10 (concomitant medications) has been updated.
 
Manufacturer Narrative
Further investigation testing was performed to rule out a potential interference.All tested parameters were within the normal range.A specific root cause could not be determined based on the provided information.No general product problem was found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREP2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg)
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250-0457
MDR Report Key17439759
MDR Text Key320253275
Report Number1823260-2023-02498
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630924998
UDI-Public04015630924998
Combination Product (y/n)Y
Reporter Country CodeHR
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Catalogue Number05168589190
Device Lot Number67400001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/04/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CONCOR COR (1 X 1); EUTHYROX (1 X 1); FURSEMID (1 X 1); NOVORAPID (2X); ROSWERA (1 X 1)
-
-